Home / XBRANE.ST : STO

AI Analysis Fundamentals Valuation Earnings Video Analysis News Similar

AI Analysis

How does XBRANE.ST make money? Does XBRANE.ST have pricing power? What's the Earnings Whisper? Will XBRANE.ST profit more as the business scales? What is XBRANE.ST's management track record? Is XBRANE.ST's current price justified?

Xbrane Biopharma AB (publ)

SEK 14.15 +$3.78 (+36.45%)

STO · 30 Oct 2026 11:59 UTC

Previous Close

SEK 13.00

Day Range

SEK 13.70SEK 15.50

Year Range

SEK 5.42SEK 20.00

Market Cap

172.27M

AVG Volume

66.72K

Trailing/Forward PE

-7.83/-

PEG ratio

0.07

Dividend Yield

Next Earnings Date

2027-02-19

Primary Exchange

Stockholm Stock Exchange

Revenue (SEK) · Q

XBRANE.ST Revenue (SEK) by quarter
Period	Revenue (SEK)
26 Q3	54.77M
26 Q2	46.75M
26 Q1	17.34M
25 Q4	9.09M
25 Q3	10.12M
25 Q2	39.9M
25 Q1	93.24M
24 Q4	65.9M
24 Q3	66.81M
24 Q2	52M

Net Income (SEK) · Q

XBRANE.ST Net Income (SEK) by quarter
Period	Net Income (SEK)
26 Q3	-11.72M
26 Q2	-11.41M
26 Q1	-13.07M
25 Q4	-26.48M
25 Q3	-24.03M
25 Q2	169.59M
25 Q1	8.16M
24 Q4	-53.2M
24 Q3	-45.12M
24 Q2	-70.5M

Operating Income (SEK) · Q

XBRANE.ST Operating Income (SEK) by quarter
Period	Operating Income (SEK)
26 Q3	-9.81M
26 Q2	-14.71M
26 Q1	-10.69M
25 Q4	-22.73M
25 Q3	-22.78M
25 Q2	-7.72M
25 Q1	27.66M
24 Q4	-31.7M
24 Q3	-37.42M
24 Q2	-63.66M

EBITDA · Q

Cash Flows · Q

EPS · Q

Expenses · Q

Cash & Debt · Q

Debt ratios · Q

Margins · Q

Return on Capital · Q

Shares Outstanding · Q

Dividends (SEK) · Q

Employee Count

Book Value Per Share · Q

Total Assets · Q

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 19 Feb 2027.

No video analysis for this stock yet. Request one from our team.

AI Analysis

Xbrane Biopharma AB (publ)

Earnings: XBRANE.ST

Video analysis: XBRANE.ST

News: XBRANE.ST

Similar companies